Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Therapies, Investigational
Malawi
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
Overview
sponsor award id
R01AI170108
Biography
contributor
Co-Principal Investigator
Time
start date
2022-07-13
end date
2027-06-30